VALUE-Dx

Randomised multicentre effectiveness trial of rapid syndromic testing by panel assay in children presenting to European emergency departments with acute respiratory infections—trial protocol for the ADEQUATE Paediatric trial

2024

Type: Protocol

Published in: BMJ Journals

Read More

VALUE-Dx: Clinical Studies Kick-off Meeting in Zeist, The Netherlands

2019

On 24 and 25 October 2019, the kick-off meeting for the VALUE-Dx ‘Clinical Studies’ work package was hosted at the Julius Centre of Health Sciences and Primary Care of the University Medical Center Utrecht in Zeist, the Netherlands.

Representatives from different community care settings, from the industry partners and from other work packages came together in preparation for the point prevalence audit survey which is planned to take place during the ‘high-peak’ winter season (January-March 2020) in 21 countries across Europe.

Read More

🇬🇧 University of Antwerp, bioMérieux, and Wellcome Trust to coordinate VALUE-Dx, a European Public-Private Partnership to fight antimicrobial resistance through diagnostics

2019

Antwerp (Belgium), London (UK), Marcy l’Etoile (France) – April 1, 2019

The University of Antwerp, bioMérieux and Wellcome Trust today announced the launch of VALUE-Dx, the first Innovative Medicines Initiative (IMI) project initiated by six in vitrodiagnostic companies who join forces with 20 non-industry partners to combat antimicrobial resistance (AMR) and improve patient outcomes. The purpose of VALUE-Dx is to transform medical practice to achieve more personalised,

Read More